Lexington International, LLC Retains World Renowned Expert in Laser Phototherapy, Michael Hamblin, Ph.D, Expanding its Scientific Advisory Board

Share Article

Lexington International, LLC, manufacturer and developer of the HairMax LaserComb® is pleased to welcome Dr. Michael Hamblin to its Scientific Advisory Board. Dr. Hamblin will provide professional expertise and guide Lexington in further understanding the biological mechanism of Photodynamic Therapy. In addition, Dr Hamblin will help Lexington model optimum energy parameters and assist in developing the most advanced and effective skincare devices for the consumer mass market.

Lexington International, LLC, manufacturer and developer of the HairMax LaserComb® is pleased to welcome Dr. Michael Hamblin to its Scientific Advisory Board. Dr. Hamblin will provide professional expertise and guide Lexington in further understanding the biological mechanism of Photodynamic Therapy. In addition, Dr Hamblin will help Lexington model optimum energy parameters and assist in developing the most advanced and effective skincare devices for the consumer mass market.

Dr. Hamblin, a premier expert in the field of laser phototherapy, obtained his Ph.D. degree in 1977 from Nottingham Trent University in England. Dr. Hamblin is a principal investigator at Wellman Center of Photomedicine at Massachusetts General Hospital and an Associate Professor at Harvard Medical School. Dr. Hamblin's primary research interests cover applications of photodynamic therapy to cancer, infections and heart disease, and the use of low-level light therapy for wound healing, hair regrowth, inflammatory disorders, and brain damage. To date, Dr. Hamblin has authored or co-authored 86 peer-reviewed scientific research papers, filed over 12 U.S. patent applications, and given over 50 invited lectures in North America, Europe, and Asia. Dr. Hamblin chairs an annual conference at SPIE Photonics West BiOS meeting in San Jose, CA entitled "Mechanisms for Low Level Light Therapy" .

Lexington is further expanding its home-use device market presence to include light phototherapy devices for skin care. The skin care device market is rapidly expanding and Lexington is poised to develop new skin care devices utilizing phototherapy technology. Lexington believes its key to success with these new skin care devices will be to develop, with Dr Hamblin's guidance, devices with optimal technical specifications and cutting-edge design both of which will ultimately provide positive user experiences.

Dr. Hamblin states, "We have demonstrated, in both clinical and laboratory settings, the benefits of photodynamic therapy (combination of non-toxic dyes and visible light), and photobiomodulation (stimulation of tissue by light alone). I believe light therapy has a great deal of utility to the general public, and I look forward to working with Lexington to provide advice on low level laser and other light therapy technology."

Co-founder and Managing Director of Lexington International, LLC, David Michaels said, "We are excited to have Dr. Hamblin, a key authoritative figure in the field of light therapy, available for advice and guidance to help Lexington maintain leadership in the low-level laser hair growth sector, and assist in our home use, skin care device development. The addition of Dr. Hamblin to our Medical Advisory Board reaffirms our commitment to continued research and contributions to the science behind light therapy devices for consumer use."

About the Medical Advisory Board
Lexington International has long been committed to facilitating positive user experiences, providing comprehensive customer support and business operation to the highest ethical standards. Lexington's Medical Advisory Board is a further extension of our dedication to quality. Each member represents a commitment to advancement of the hair care industry through ethical and credible practices, and is individually responsible for great contributions to the community. As a whole, the Medical Advisory Board can apply its expertise and credentials to support Lexington as we continue our efforts in providing a quality product to our customers. The Board consists of many established Key Authoritative Figures in the hair loss field who can attest first-hand to the efficacy of low level laser therapy in the treatment of Androgenetic Alopecia. In fact, these respected professionals have chosen to support our product based upon their experiences and belief that the HairMax LaserComb provides beneficial results.

For more information, please visit http://www.hairmax.com/advisoryboard/

About Lexington International, LLC
Originating in Sydney Australia and now based in Boca Raton Florida, Lexington manufactures and distributes the HairMax LaserComb® (http://www.hairmax.com) to more than 89 countries and has provided new hope and satisfaction to tens of thousands of customers since 2001.

The HairMax LaserComb is the first and only FDA cleared hand-held laser device that utilizes low-level laser therapy to improve the appearance of hair at an affordable price. With no reported side effects, and an incomparable satisfaction rate, the LaserComb is revolutionizing the hair care industry. The HairMax LaserComb is based on 20 years of international research and studies on the effects of Low Level Laser use. Both the press and users alike have universally taken to the HairMax LaserComb. HairMax is the first and only device Cleared by the FDA from Promotion of Hair Growth, in Jan 2007 which was a regulatory milestone.

Lexington is an ISO 9001 & 13485 Quality Assured laser manufacturer. Lexington is committed to GMP (Good Manufacturing Practices) of a medical device manufacturer. Clinical studies closely adhered to GCP (Good Clinical Practices) reviewed by an IRB (Ethics Committee). Lexington is also a member in good standing of the Better Business Bureau.

Contact:

Lexington International, LLC
Attention: Media Relations
561-417-0200
mediarelations @ hairmax.com
http://www.hairmax.com

# # #

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Media Relations
Visit website